Abstract B128: Efficacy of RP4010, a calcium release-activated calcium (CRAC) inhibitor, in preclinical models of DLBCL
Sign Up to like & getrecommendations! Published in 2018 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.targ-17-b128
Abstract: Background: Diffuse large B-cell lymphoma (DLBCL) is an aggressive, rapidly growing type of lymphoma that comprises 30-40% of NHL cases. Chemotherapy remains the most widely used treatment for DLBCL, thereby necessitating the need to develop… read more here.
Keywords: models dlbcl; efficacy; rp4010; preclinical models ... See more keywords